These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 26687611)
1. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis. Kim SJ; Choi JY; Hyun SH; Ki CS; Oh D; Ahn YC; Ko YH; Choi S; Jung SH; Khong PL; Tang T; Yan X; Lim ST; Kwong YL; Kim WS; Lancet Haematol; 2015 Feb; 2(2):e66-74. PubMed ID: 26687611 [TBL] [Abstract][Full Text] [Related]
2. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Kim SJ; Yoon DH; Jaccard A; Chng WJ; Lim ST; Hong H; Park Y; Chang KM; Maeda Y; Ishida F; Shin DY; Kim JS; Jeong SH; Yang DH; Jo JC; Lee GW; Choi CW; Lee WS; Chen TY; Kim K; Jung SH; Murayama T; Oki Y; Advani R; d'Amore F; Schmitz N; Suh C; Suzuki R; Kwong YL; Lin TY; Kim WS Lancet Oncol; 2016 Mar; 17(3):389-400. PubMed ID: 26873565 [TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL. Lim SH; Hyun SH; Kim HS; Lee JY; Yoo KH; Jung KS; Song HN; Cho J; Park S; Ko YH; Kim SJ; Choi JY; Kim WS Bone Marrow Transplant; 2016 Jun; 51(6):807-12. PubMed ID: 26855154 [TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT for Prognostic Stratification of Patients With Extranodal Natural Killer/T-Cell Lymphoma. Qin C; Yang S; Sun X; Xia X; Li C; Lan X Clin Nucl Med; 2019 Mar; 44(3):201-208. PubMed ID: 30624268 [TBL] [Abstract][Full Text] [Related]
5. Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma. Cho J; Kim SJ; Park S; Yoo KH; Ki CS; Ko Y; Kim WS Ann Hematol; 2018 Aug; 97(8):1427-1436. PubMed ID: 29627879 [TBL] [Abstract][Full Text] [Related]
6. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase. Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis. Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243 [TBL] [Abstract][Full Text] [Related]
8. Appropriate timing to perform an interim Wang R; Zhang Y; Fan Q; Jiang M; Zou L; Su M Ann Hematol; 2024 Mar; 103(3):885-892. PubMed ID: 38030892 [TBL] [Abstract][Full Text] [Related]
9. A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score. Yhim HY; Park Y; Han YH; Kim S; Kang SR; Moon JH; Jeong JH; Shin HJ; Kim K; Choi YS; Kim K; Kim MK; Kong E; Kim DS; Eo JS; Lee JH; Kang DY; Lee WS; Lee SM; Do YR; Ham JS; Kim SJ; Kim WS; Choi JY; Yang DH; Kwak JY Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2274-2284. PubMed ID: 30056546 [TBL] [Abstract][Full Text] [Related]
10. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type. Xu PP; Xiong J; Cheng S; Zhao X; Wang CF; Cai G; Zhong HJ; Huang HY; Chen JY; Zhao WL EBioMedicine; 2017 Nov; 25():41-49. PubMed ID: 29056540 [TBL] [Abstract][Full Text] [Related]
11. Dynamic evaluation of the prognostic value of Xu P; Guo R; You J; Cheng S; Li J; Zhong H; Sun C; Xu H; Huang H; Li B; Zhao W Ann Hematol; 2021 Apr; 100(4):1039-1047. PubMed ID: 33634350 [TBL] [Abstract][Full Text] [Related]
12. Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein-Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol. Wang XX; Li PF; Bai B; Gao Y; Rong QX; Cai QQ; Lin SX; Zhang YJ; Li ZM; Jiang WQ; Huang HQ Leuk Lymphoma; 2019 Aug; 60(8):1917-1925. PubMed ID: 30646796 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type. Jiang C; Zhang X; Jiang M; Zou L; Su M; Kosik RO; Tian R Ann Nucl Med; 2015 Jun; 29(5):442-51. PubMed ID: 25801633 [TBL] [Abstract][Full Text] [Related]
14. Early risk stratification for diffuse large B-cell lymphoma integrating interim Deauville score and International Prognostic Index. Yim SK; Yhim HY; Han YH; Jeon SY; Lee NR; Song EK; Jeong HJ; Kim HS; Kwak JY Ann Hematol; 2019 Dec; 98(12):2739-2748. PubMed ID: 31712879 [TBL] [Abstract][Full Text] [Related]
15. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China. Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951 [TBL] [Abstract][Full Text] [Related]
16. The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphoma. Huang HL; Ngam PI; Tan KM; Ng DCE; Lim ST; Chan JY Ann Nucl Med; 2021 May; 35(5):557-568. PubMed ID: 33683545 [TBL] [Abstract][Full Text] [Related]
17. Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center. Khong PL; Huang B; Lee EY; Chan WK; Kwong YL J Nucl Med; 2014 Jun; 55(6):911-6. PubMed ID: 24819420 [TBL] [Abstract][Full Text] [Related]
18. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis. Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537 [TBL] [Abstract][Full Text] [Related]
19. Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK/T cell lymphoma is associated with better prognosis. Kim WY; Jung HY; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK Virchows Arch; 2016 Nov; 469(5):581-590. PubMed ID: 27595782 [TBL] [Abstract][Full Text] [Related]
20. Predictive approaches for post-therapy PET/CT in patients with extranodal natural killer/T-cell lymphoma: a retrospective study. Jiang C; Liu J; Li L; Kosik RO; Su M; Zou L; Tian R Nucl Med Commun; 2017 Nov; 38(11):937-947. PubMed ID: 28858180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]